Compare Edwards Lifesciences Corporation Common Stock (EW) vs Rockwell Automation (ROK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Rockwell Automation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.59 (market cap $48.56B), while Rockwell Automation trades at $433.07 (market cap $48.21B). The key difference: Edwards Lifesciences Corporation Common Stock and Rockwell Automation are close in size by market cap, and Rockwell Automation pays a 1.27% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | ROK | |
|---|---|---|
Market Cap | $48.56B | $48.21B |
Volume | 6,520,488 | 953,342 |
Sector | Health | Industrials |
52-Week High | $95.18 | $495.08 |
52-Week Low | $72.65 | $333.75 |
Enterprise Value | $45.01B | $51.34B |
Typical Hold Time | — | 74 Days |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Rockwell Automation (ROK) trades at $432.61, down 2.1% on the day, with a bearish technical signal. The stock shows strong profitability with a 13.38% net income margin and 34.47% ROE, but trades at elevated valuation multiples including a P/E of 40.65. Recent earnings have consistently beaten estimates, and the company maintains a solid cash flow profile. Positive news highlights its leadership in industrial automation and digital transformation initiatives.
The outlook is mixed: analyst consensus is a Buy with a $489.89 price target, implying potential upside, but high valuation and near-term technical weakness pose risks. Key catalysts include continued execution on automation demand trends, while risks involve macroeconomic sensitivity and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Rockwell Automation
Rockwell Automation is a pure-play automation competitor that is the successor entity to Rockwell International, which spun off its former Rockwell Collins avionics segment in 2001. As of fiscal 2021, the firm operates through three segments--intelligent devices, software and control, and lifecycle services. Intelligent devices contains its drives, sensors, and industrial components, software and control contains its information and network and security software, while lifecycle services contains its consulting and maintenance services as well as its Sensia JV with Schlumberger.
Read more on ROK →
